Table 6.
Successful outcome | Risk ratio | [95% CI] | P value | |
---|---|---|---|---|
Sex | ||||
Female | 60/62 (97.8) | 1 | ||
Male | 148/162 (91.4) | 0.94 | 0.88–1.01 | 0.24 |
Age group | ||||
00–24 | 19/19 (100) | 1 | ||
25–44 | 117/124 (94.4) | 0.94 | 0.90–0.99 | 0.59 |
45–64 | 60/67 (89.6) | 0.90 | 0.83–0.97 | 0.34 |
65 and + | 12/14 (85.7) | 0.86 | 0.69–1.06 | 0.17 |
Type of TB | ||||
NPBCT | 2803/3124 (89.7) | 1 | ||
Relapse | 133/140 (95) | 1.06 | 1.02–1.10 | 0.04 |
Failure | 63/69 (91.3) | 1.02 | 0.95–1.10 | 0.67 |
Treatment after loss to follow-up | 12/15 (80) | 0.89 | 0.69–1.15 | 0.19 |
HIV status | ||||
HIV negative | 169/181 (93.4) | 1 | ||
HIV positive | 38/39 (97) | 1.04 | 0.98–1.11 | 0.47 |
HIV status unknown | 1/4 (25) | 0.27 | 0.05–1.46 | 0.001 |
Region | ||||
Atacora-Donga | 13/14 (92.9) | 1.01 | 0.86–1.18 | 1 |
Borgou-Alibori | 9/11 (81.8) | 0.89 | 0.67–1.10 | 0.26 |
Zou-Collines | 28/30 (93.3) | 1.02 | 0.91–1.14 | 1 |
Mono-Couffo | 27/28 (96.4) | 1.05 | 0.96–1.15 | 0.68 |
Oueme-Plateau | 40/42 (95.2) | 1.04 | 0.95–1.13 | 0.72 |
Atlantique-Littoral | 91/99 (91.9) | 1 |
Note: NPBCT: new pulmonary bacteriologically confirmed tuberculosis; TB: tuberculosis.